Cargando…

Naturally Occurring Oxazole-Containing Peptides

Oxazole-containing peptides are mostly of marine origin and they form an intriguing family with a broad range of biological activities. Here we classify these peptides on the basis of their chemical structure and discuss a number of representatives of each class that reflect the extraordinary potent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mhlongo, Jessica T., Brasil, Edikarlos, de la Torre, Beatriz G., Albericio, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231064/ https://www.ncbi.nlm.nih.gov/pubmed/32290087 http://dx.doi.org/10.3390/md18040203

Ejemplares similares

Antimicrobial Peptide Synergies for Fighting Infectious Diseases
por: Mhlongo, Jessica T., et al.
Publicado: (2023)

Protocol for efficient solid-phase synthesis of peptides containing 1-hydroxypyridine-2-one (1,2-HOPO)
por: Al Shaer, Danah, et al.
Publicado: (2020)

Peptide Therapeutics 2.0
por: de la Torre, Beatriz G., et al.
Publicado: (2020)

Methionine-Containing Peptides: Avoiding Secondary Reactions in the Final Global Deprotection
por: Nandhini, K. P., et al.
Publicado: (2023)

The genomic landscape of ribosomal peptides containing thiazole and oxazole heterocycles
por: Cox, Courtney L., et al.
Publicado: (2015)

2017 FDA Peptide Harvest
por: Al Musaimi, Othman, et al.
Publicado: (2018)

Practical Protocols for Solid-Phase Peptide Synthesis 4.0
por: de la Torre, Beatriz G., et al.
Publicado: (2022)

2019 FDA TIDES (Peptides and Oligonucleotides) Harvest
por: Al Shaer, Danah, et al.
Publicado: (2020)

2020 FDA TIDES (Peptides and Oligonucleotides) Harvest
por: Al Musaimi, Othman, et al.
Publicado: (2021)

2021 FDA TIDES (Peptides and Oligonucleotides) Harvest
por: Al Shaer, Danah, et al.
Publicado: (2022)

The Pharmaceutical Industry in 2019. An Analysis of FDA Drug Approvals from the Perspective of Molecules
por: de la Torre, Beatriz G., et al.
Publicado: (2020)

The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of Molecules
por: de la Torre, Beatriz G., et al.
Publicado: (2018)

The Pharmaceutical Industry in 2018. An Analysis of FDA Drug Approvals from the Perspective of Molecules
por: G. de la Torre, Beatriz, et al.
Publicado: (2019)

The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule Type
por: de la Torre, Beatriz G., et al.
Publicado: (2017)

The Pharmaceutical Industry in 2020. An Analysis of FDA Drug Approvals from the Perspective of Molecules
por: de la Torre, Beatriz G., et al.
Publicado: (2021)

The Pharmaceutical Industry in 2021. An Analysis of FDA Drug Approvals from the Perspective of Molecules
por: de la Torre, Beatriz G., et al.
Publicado: (2022)

The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules
por: de la Torre, Beatriz G., et al.
Publicado: (2023)

2022 FDA TIDES (Peptides and Oligonucleotides) Harvest
por: Al Musaimi, Othman, et al.
Publicado: (2023)

Understanding Tetrahydropyranyl as a Protecting Group in Peptide Chemistry
por: Sharma, Anamika, et al.
Publicado: (2017)

An Overview of Bioactive 1,3-Oxazole-Containing Alkaloids from Marine Organisms
por: Chen, Jinyun, et al.
Publicado: (2021)

Amino-Li-Resin—A Fiber Polyacrylamide Resin for Solid-Phase Peptide Synthesis
por: Akintayo, Damilola C., et al.
Publicado: (2022)

Recent Advances in the Synthesis of Oxazole-Based Molecules via van Leusen Oxazole Synthesis
por: Zheng, Xunan, et al.
Publicado: (2020)

Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate
por: Sheyi, Rotimi, et al.
Publicado: (2022)

Revisiting NO(2) as Protecting Group of Arginine in Solid-Phase Peptide Synthesis
por: Alhassan, Mahama, et al.
Publicado: (2020)

Scope and Limitations of γ-Valerolactone (GVL) as a Green Solvent to be Used with Base for Fmoc Removal in Solid Phase Peptide Synthesis
por: Kumar, Ashish, et al.
Publicado: (2019)

FDA Approvals of Biologics in 2022
por: Martins, Alexander C., et al.
Publicado: (2023)

A Practical Peptide Synthesis Workflow Using Amino-Li-Resin
por: Akintayo, Damilola Caleb, et al.
Publicado: (2022)

Novel Biomimetic Human TLR2-Derived Peptides for Potential Targeting of Lipoteichoic Acid: An In Silico Assessment
por: Devnarain, Nikita, et al.
Publicado: (2021)

Thiazole and Oxazole Alkaloids: Isolation and Synthesis
por: Davyt, Danilo, et al.
Publicado: (2010)

Edible Plants Containing Naturally Occurring Carcinogens in Japan
por: Hirono, Iwao
Publicado: (1993)

2018 FDA Tides Harvest
por: Al Shaer, Danah, et al.
Publicado: (2019)

Understanding OxymaPure as a Peptide Coupling Additive: A Guide to New Oxyma Derivatives
por: Manne, Srinivasa Rao, et al.
Publicado: (2022)

Solid-Phase Synthesis of an “Inaccessible” hGH-Derived Peptide Using a Pseudoproline Monomer and SIT-Protection for Cysteine
por: Manne, Srinivasa Rao, et al.
Publicado: (2022)

Tetrahydropyranyl: A Non‐aromatic, Mild‐Acid‐Labile Group for Hydroxyl Protection in Solid‐Phase Peptide Synthesis
por: Sharma, Anamika, et al.
Publicado: (2017)

s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation
por: Sharma, Anamika, et al.
Publicado: (2021)

Super-Cationic Peptide Dendrimers—Synthesis and Evaluation as Antimicrobial Agents
por: Ramchuran, Estelle J., et al.
Publicado: (2021)

α,β-Dehydroamino acids in naturally occurring peptides
por: Siodłak, Dawid
Publicado: (2014)

A comprehensive review on biological activities of oxazole derivatives
por: Kakkar, Saloni, et al.
Publicado: (2019)

TOMBU and COMBU as Novel Uronium-Type Peptide Coupling Reagents Derived from Oxyma-B
por: Jad, Yahya E., et al.
Publicado: (2014)

Insights into the chemistry of the amphibactin–metal (M(3+)) interaction and its role in antibiotic resistance
por: Kaipanchery, Vidya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v8rso1d9g1b6jl0fgf2beeo423